Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Published Online: 2013-01-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: David Lebwohl•David Neal Franz•E Martina Bebin•Elena Belousova•Elizabeth A Thiele•Gaurav Shah•Helene Cauwel•J Robert Flamini•James P Ford•Joyce Y Wu•Michael Frost•Michael H Kohrman•Olaf Witt•Paolo Curatolo•Petrus J de Vries•Rachel Kuperman•Sergiusz Jozwiak•Steven Sparagana•Tarek Sahmoud•Vicky H Whittemore